ENDECE is a pioneering biopharmaceutical company based in Portland, OR, dedicated to shaping a healthier future for individuals grappling with severe and life-threatening illnesses. With a strong focus on addressing the needs of these individuals, ENDECE has developed a remarkable library of proprietary compounds. These compounds possess a unique ability to modify specific gene expression, ultimately restoring function and hope to those affected.

Comprised of esteemed scientific minds and industry leaders, the ENDECE team embarks on a journey to achieve significant regulatory and clinical milestones, greatly enhancing the quality of life for countless individuals. From the devastating realms of ARDS, COVID-19, Multiple Sclerosis, Alzheimer's Disease, Neuromyelitis Optica Spectrum Disorder, to Niemann-Pick disease type C and Osmotic Demyelination Syndrome, ENDECE confronts these challenges head-on. Stay connected with ENDECE through their Facebook page and be part of their mission to build a healthier future